28179361|t|A microbial signature for Crohn's disease
28179361|a|A decade of microbiome studies has linked IBD to an alteration in the gut microbial community of genetically predisposed subjects. However, existing profiles of gut microbiome dysbiosis in adult IBD patients are inconsistent among published studies, and did not allow the identification of microbial signatures for CD and UC. Here, we aimed to compare the faecal microbiome of CD with patients having UC and with non - IBD subjects in a longitudinal study. We analysed a cohort of 2045 non - IBD and IBD faecal samples from four countries (Spain, Belgium, the UK and Germany), applied a 16S rRNA sequencing approach and analysed a total dataset of 115 million sequences. In the Spanish cohort, dysbiosis was found significantly greater in patients with CD than with UC, as shown by a more reduced diversity, a less stable microbial community and eight microbial groups were proposed as a specific microbial signature for CD. Tested against the whole cohort, the signature achieved an overall sensitivity of 80% and a specificity of 94%, 94%, 89% and 91% for the detection of CD versus healthy controls, patients with anorexia, IBS and UC, respectively. Although UC and CD share many epidemiologic, immunologic, therapeutic and clinical features, our results showed that they are two distinct subtypes of IBD at the microbiome level. For the first time, we are proposing microbiomarkers to discriminate between CD and non - CD independently of geographical regions.
28179361	2	11	microbial	T001	C0599840
28179361	12	21	signature	T169	C1704864
28179361	26	41	Crohn's disease	T047	C0010346
28179361	44	50	decade	T081	C2981279
28179361	54	64	microbiome	T001	C1956108
28179361	65	72	studies	T062	C2603343
28179361	84	87	IBD	T047	C0021390
28179361	94	104	alteration	T078	C1515926
28179361	112	115	gut	T023	C0699819
28179361	116	125	microbial	T001	C0599840
28179361	126	135	community	T096	C0009462
28179361	139	150	genetically	T169	C0314603
28179361	151	162	predisposed	T169	C0231203
28179361	163	171	subjects	T098	C0080105
28179361	191	199	profiles	T059	C1979963
28179361	203	206	gut	T023	C0699819
28179361	207	217	microbiome	T001	C1956108
28179361	218	227	dysbiosis	T046	C3658208
28179361	231	236	adult	T100	C0001675
28179361	237	240	IBD	T047	C0021390
28179361	241	249	patients	T101	C0030705
28179361	254	266	inconsistent	T080	C0442809
28179361	273	282	published	T057	C0034037
28179361	283	290	studies	T062	C2603343
28179361	314	328	identification	T080	C0205396
28179361	332	341	microbial	T001	C0599840
28179361	342	352	signatures	T169	C1704864
28179361	357	359	CD	T047	C0010346
28179361	364	366	UC	T047	C0009324
28179361	377	382	aimed	T078	C1947946
28179361	386	393	compare	T052	C1707455
28179361	398	404	faecal	T031	C0015733
28179361	405	415	microbiome	T001	C1956108
28179361	419	421	CD	T047	C0010346
28179361	427	435	patients	T101	C0030705
28179361	443	445	UC	T047	C0009324
28179361	455	458	non	T169	C0332197
28179361	461	464	IBD	T047	C0021390
28179361	465	473	subjects	T098	C0080105
28179361	479	497	longitudinal study	T062	C0023981
28179361	513	519	cohort	T098	C0599755
28179361	528	531	non	T169	C0332197
28179361	534	537	IBD	T047	C0021390
28179361	542	545	IBD	T047	C0021390
28179361	546	552	faecal	T031	C0015733
28179361	553	560	samples	T167	C0370003
28179361	571	580	countries	T083	C0454664
28179361	582	587	Spain	T083	C0037747
28179361	589	596	Belgium	T083	C0004950
28179361	602	604	UK	T083	C0041700
28179361	609	616	Germany	T083	C0017480
28179361	629	648	16S rRNA sequencing	T059	C3258987
28179361	679	686	dataset	T170	C0150098
28179361	702	711	sequences	T086	C0162327
28179361	720	727	Spanish	T098	C0086409
28179361	728	734	cohort	T098	C0599755
28179361	736	745	dysbiosis	T046	C3658208
28179361	756	777	significantly greater	T081	C4055637
28179361	781	789	patients	T101	C0030705
28179361	795	797	CD	T047	C0010346
28179361	808	810	UC	T047	C0009324
28179361	831	838	reduced	T080	C0392756
28179361	839	848	diversity	T080	C1880371
28179361	857	863	stable	T080	C0205360
28179361	864	873	microbial	T001	C0599840
28179361	874	883	community	T096	C0009462
28179361	894	903	microbial	T001	C0599840
28179361	904	910	groups	T078	C0441833
28179361	916	924	proposed	T080	C1553874
28179361	930	938	specific	T080	C0205369
28179361	939	948	microbial	T001	C0599840
28179361	949	958	signature	T169	C1704864
28179361	963	965	CD	T047	C0010346
28179361	967	973	Tested	T169	C0039593
28179361	992	998	cohort	T098	C0599755
28179361	1004	1013	signature	T169	C1704864
28179361	1034	1045	sensitivity	T081	C0036667
28179361	1059	1070	specificity	T081	C0037791
28179361	1104	1113	detection	T061	C1511790
28179361	1117	1119	CD	T047	C0010346
28179361	1127	1134	healthy	T080	C3898900
28179361	1135	1143	controls	T096	C0009932
28179361	1145	1153	patients	T101	C0030705
28179361	1159	1167	anorexia	T047	C0003123
28179361	1169	1172	IBS	T047	C0022104
28179361	1177	1179	UC	T047	C0009324
28179361	1204	1206	UC	T047	C0009324
28179361	1211	1213	CD	T047	C0010346
28179361	1225	1238	epidemiologic	T169	C0014508
28179361	1240	1251	immunologic	T169	C0205470
28179361	1253	1264	therapeutic	T169	C0302350
28179361	1269	1277	clinical	T080	C0205210
28179361	1278	1286	features	T080	C2348519
28179361	1292	1299	results	T169	C1274040
28179361	1334	1342	subtypes	T185	C0449560
28179361	1346	1349	IBD	T047	C0021390
28179361	1357	1367	microbiome	T001	C1956108
28179361	1368	1373	level	T080	C0441889
28179361	1383	1388	first	T080	C1279901
28179361	1389	1393	time	T079	C0040223
28179361	1412	1427	microbiomarkers	T201	C0005516
28179361	1431	1443	discriminate	T080	C0205235
28179361	1452	1454	CD	T047	C0010346
28179361	1459	1462	non	T169	C0332197
28179361	1465	1467	CD	T047	C0010346
28179361	1485	1505	geographical regions	T083	C0017446